RESEARCH TRIANGLE PARK, N.C. – December 1, 2011 – Continuing the expansion of its Global Laboratories’ capabilities and resources, Quintiles today announced the opening of a new, expanded central lab in Centurion, South Africa, further adding to its world-leading network of fully harmonized, College of American Pathologists (CAP)-accredited central labs.
Quintiles’ new 7,500-square-foot lab offers expanded testing capabilities – covering tuberculosis, microbiology services, HIV, immunofluorescence and flow cytometry – to address a wider range of studies across multiple therapeutic areas throughout sub-Saharan Africa.
“This facility has the latest technology and equipment which, combined with our rigorous CAP-accredited standards and practices, will speed the delivery of clean, reliable and comparable data to customers and investigators,” said Graham Murray, Head of Quintiles Global Laboratories in the Europe, Middle East and Africa. “It further enhances our ability to help customers accelerate clinical development in multiple geographies and disease areas.”
Quintiles recently added Advion Bioanalytical Labs, a premier U.S.-based bioanalytical laboratory, to its Global Laboratories network. With advanced bioanalytical and metabolic lab services from Quintiles, customers can gain early insight into a drug’s interaction in the body, which helps inform decision-making and reduce the risk of failure in expensive later-stage trials.
Quintiles Global Laboratories support studies worldwide through wholly owned facilities in the U.S., Europe, South Africa, India, China, Singapore and Japan, and a tightly coordinated network of affiliate labs in Argentina and Brazil. All Quintiles laboratories operate with uniform instrumentation and standard operating procedures, delivering high quality, harmonized data.
Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more than 20,000 engaged professionals in 60 countries works with an unwavering commitment to patients, safety and ethics. Quintiles helps biopharmaceutical companies navigate risk and seize opportunities in an environment where change is constant. For more information, please visit www.quintiles.com.